11-19880003-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145117.5(NAV2):c.646G>A(p.Ala216Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A216G) has been classified as Uncertain significance.
Frequency
Consequence
NM_145117.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NAV2 | NM_145117.5 | c.646G>A | p.Ala216Thr | missense_variant | 5/38 | ENST00000349880.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NAV2 | ENST00000349880.9 | c.646G>A | p.Ala216Thr | missense_variant | 5/38 | 1 | NM_145117.5 |
Frequencies
GnomAD3 genomes ? AF: 0.000270 AC: 41AN: 152042Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000220 AC: 55AN: 249698Hom.: 1 AF XY: 0.000222 AC XY: 30AN XY: 135088
GnomAD4 exome AF: 0.000135 AC: 197AN: 1461564Hom.: 0 Cov.: 31 AF XY: 0.000127 AC XY: 92AN XY: 727078
GnomAD4 genome ? AF: 0.000269 AC: 41AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.646G>A (p.A216T) alteration is located in exon 5 (coding exon 5) of the NAV2 gene. This alteration results from a G to A substitution at nucleotide position 646, causing the alanine (A) at amino acid position 216 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at